Takeda Pharmaceuticals U.S.A., Inc. v. Granules Pharmaceuticals, Inc.
1:20-cv-00812
Overview
Parties
Defendant
Granules Pharmaceuticals, Inc. Operating Company
Represented By
4 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Smith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
Plaintiff
Takeda Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
6 Attorneys ListedFaegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Faegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Dr. Reddy's Laboratories, Ltd.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
Takeda Pharmaceuticals U.S.A., Inc. v. Hikma Pharmaceuticals USA, Inc.
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.
Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7906519
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-08-18
Issued: 2011-03-15
|
Active (3.7 yrs remaining)
Expires: 2030-08-18
|
|
|
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2010-05-25
Issued: 2011-05-03
|
Active (3.5 yrs remaining)
Expires: 2030-05-25
|
|
|
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-18
Issued: 2012-01-10
|
Active (4.5 yrs remaining)
Expires: 2031-05-18
|
|
|
US7964648
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-01-15
Issued: 2011-06-21
|
Active (3.2 yrs remaining)
Expires: 2030-01-15
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
6
Dispositive
0
Granted
0
Denied
0
Pending / Review
4
Motions by Category
Key Dispositive Motions & Rulings